Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Adults
Condition: HSV Infection Interventions: Drug: Pritelivir; Drug: Foscarnet Injection [Foscavir] Sponsors: AiCuris Anti-infective Cures GmbH; Medpace, Inc. Not yet recruiting - verified March 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials